// App-Quantinova.ai

Sa1192 : Agreement of Central Readers in the Evaluation of Histopathological Disease Activity in Ulcerative Colitis

Researchers

Presenter

  • Brian G. Feagan

Principal Investigators

  • Guangyong Zou

  • Keith J. Kaplan

  • Lisa M. Shackelton

  • Jay Jones

  • Reena Khanna

  • Barrett G. Levesque

  • Karel Geboes

  • Cord Langner

  • Michael R. Peterson

  • Rish Pai

  • William Sandborn

  • Geert R. -Haens

  • Margaret K. Vandervoort

  • Cynthia Behling

Medical Centers

  • University Hospitals Leuven and KU Leuven, Leuven, Belgium

  • University of California, San Diego, La Jolla, CA

  • Department of Epidemiology and Biostatistics, Western University, London, ON, Canada

  • Institute of Pathology, Medical University of Graz, Graz, Austria

  • Faculty of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia.

  • Carolinas Medical Center, Charlotte, NC

  • Department of Anatomic Pathology, Cleveland Clinic, Cleveland, OH

  • University of Amsterdam, Amsterdam, Belgium

  • Western Washington Pathology and Multicare Health System, Tacoma, WA

Locations

  • Canada

  • Saudi Arabia

  • Austria

  • United States

  • Belgium

Companies

  • Robarts Clinical Tri

  • Pacific Rim Patholog

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Ulcerative colitis

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim